IN THE NEWS

THE LATEST NEWS

Virtual Patients, Real Results: How Digital Twins Are Reshaping Drug Development

Causal artificial intelligence and digital twins are transforming drug discovery and development

Digital Twins of Biological Systems Inform Drug Development

AI for target discovery: the start of a long road.

Aitia’s CEO Wants You to Use AI to Do More than Designing Drugs Against Known Validated Targets

Digital Twins: When AI drives progress for the pharmaceutical industry

How Digital Twins are Transforming Medicine

Unveiling the AI Dominance in Biopharma: STAT Post JPM Conference Insights

Servier Will Apply Aitia’s Gemini Digital Twins to Parkinson’s Drug

Partner of Choice: Aitia and Servier Revolutionize the Landscape of Pancreatic Cancer Treatment